Laura de Girolamo, PhD was born and grew up in Italy, where she received her MSc in Biology and Ph.D from the University of Milan. She got her post-doctoral training between the Galeazzi Orthopaedic Institute and other international centers among which the Brigham and Women’s Hospital – Harvard University of Boston.
She is currently the Director of the Orthopaedic Biotechnology Laboratory of the Galeazzi Orthopaedic Institute in Milan and of the platform RE.GA.IN® (Regenerative Galeazzi Institute). Her basic and translational research focus is on mesenchymal stem cells, particularly derived from adipose tissue and tendons.
The goal of Dr. de Girolamo’s laboratory is to derive biological solutions aimed to promote cartilage, tendon and bone regeneration by improving activity and clinical therapeutic potential of MSCs. She served as PI or co-PI in several research projects collaborating with national and international research centers. She is author of more than 100 peer-reviewed papers and 10 book chapters in orthopedics and regenerative medicine.
She has been invited speaker at several national and international congresses and courses. From 2016 to 2020 she was Chairwoman of the Basic Science Committee of the European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA) and she is currently co-leading the ESSKA Orthobiologics Initiative. From 2016 she is Chairwoman of the Research Committee of Italian Knee Surgery Arthroscopy Sports and Cartilage Society (SIAGASCOT). She was co-founder of the Italian Mesenchymal Stem Cell Group (GISM) and currently member of the Executive Committee.
She is Associate Editors of Journal Of Experimental Orthopaedics and Joints, and member of the Editorial Board of Knee Surgery Sport Traumatology Arthroscopy (KSSTA). She has also been Guest Editors and reviewers for many peer-reviewed Journals and in both Orthopaedics and Basic Science field.
